" BioCure Technology Inc. (CSE:CURE) provides corporate updates
BioCure Technology (CURE) has appointed a new president, a Capital Markets Advisor and granted stock options to directors, employees and consultants.
" BetterLife (CSE:BETR) partners with Carleton University to research treatment for chronic anxiety
BetterLife Pharma (BETR) has received funding for its joint research with Carleton University into the use of TD-010 to treat chronic anxiety and
" Advanced Proteome Therapeutics (TSXV:APC) appoints Dr. Benjamin Krantz as CEO
Dr. Benjamin Krantz has assumed the role of CEO at Advanced Proteome Therapeutics’ (APC) US subsidiary, Advanced Proteome Therapeutics Inc.
" DIAGNOS (TSXV:ADK) begins clinical trial for the detection and prevention of stroke using its new application CARA-STROKE
Diagnos (ADK) has begun a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC.